High-density lipoprotein levels are strongly associated with the recovery rate of insulin sensitivity during the acute phase of myocardial infarction: A study by euglycemic hyperinsulinemic clamp

Journal of Clinical Lipidology

Volumn 7, Issue 1, 2013, Pages 24-28

  Carvalho, Luiz Sergio F ^a   Martins, Naiara V ^b   Moura, Filipe A ^b   Cintra, Riobaldo M R ^a   Almeida, Osorio L R ^b,c   Quinaglia E Silva, Jose C ^b,c   Sposito, Andrei C ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c HOSPITAL DE BASE DO DISTRITO FEDERAL   (Brazil)

Author keywords

Euglycemic hyperinsulinemic clamp; HDL; Insulin sensitivity; Myocardial infarction

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; SIMVASTATIN; TRIACYLGLYCEROL; TROPONIN I;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR MAGNETIC RESONANCE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; INSULIN SENSITIVITY; LIPOPROTEIN BLOOD LEVEL; MALE; METABOLIC STRESS; PRIORITY JOURNAL; SMOKING; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; WAIST CIRCUMFERENCE;

ACUTE DISEASE; AGE FACTORS; AGED; BLOOD CHEMICAL ANALYSIS; FEMALE; GLUCOSE CLAMP TECHNIQUE; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INSULIN RESISTANCE; LIPOPROTEINS, HDL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 84872909369     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2012.10.003     Document Type: Article

References (14)

1. P.J. Stubbs, J. Alaghband-Zadeh, J.F. Laycock, P.O. Collinson, G.D. Carter, and M.I. Noble Significance of an index of insulin resistance on admission in non-diabetic patients with acute coronary syndromes Heart 82 1999 443 447
2. C. Lazzeri, A. Sori, M. Chiostri, G.F. Gensini, and S. Valente Prognostic role of insulin resistance as assessed by homeostatic model assessment index in the acute phase of myocardial infarction in nondiabetic patients submitted to percutaneous coronary intervention Eur J Anaesthesiol 26 2009 856 862
3. M. Falciglia Causes and consequences of hyperglycemia in critical illness Curr Opin Clin Nutr Metab Care 10 2007 498 503
4. D.F. Heath Glucose, insulin and other plasma metabolites shortly after injury J Accid Emerg Med 11 1994 67 77
5. F. van Kooten, N. Hoogerbrugge, P. Naarding, and P.J. Koudstaal Hyperglycemia in the acute phase of stroke is not caused by stress Stroke 24 1993 1129 1132
6. B.G. Drew, S.J. Duffy, and M.F. Formosa High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus Circulation 119 2009 2103 2111
7. R. Han, R. Lai, and Q. Ding Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism Diabetologia 50 2007 1960 1968
8. B.G. Drew, A.L. Carey, and A.K. Natoli Reconstituted high-density lipoprotein infusion modulates fatty acid metabolism in patients with type 2 diabetes mellitus J Lipid Res 52 2011 572 581
9. L.S. Carvalho, R.M. Cintra, F.A. Moura Brasilia Heart Study Group High plasma HDL-C attenuates stress hyperglycemia during acute phase of myocardial infarction Atherosclerosis 220 2012 231 236
10. A. Katz, S.S. Nambi, and K. Mather Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans J Clin Endocrinol Metab 85 2000 2402 2410
11. P.J. Barter, K.A. Rye, and J.C. Tardif Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial Circulation 124 2011 555 562
12. J. Sierra-Johnson, A. Romero-Corral, and V.K. Somers ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects Eur Heart J 28 2007 2637 2643
13. A.G. Olsson, G.G. Schwartz, and M. Szarek High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial Eur Heart J 26 2005 890 896
14. G.G. Schwartz High-density lipoprotein cholesterol as a risk factor and target of therapy after acute coronary syndrome Am J Cardiol 104 2009 46E 51E